Vestal Point Capital »

Geron Corporation shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Geron Corporation (GERN) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Geron Corporation

Tip: Access up to 7 years of quarterly data

All positions including Geron Corporation held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Geron Corporation by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.8M 1.1M 4.54

More positions owned by Vestal Point Capital

Insmed Com Par $.01 (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Inari Medical Ord (NARI)
Arcellx Common Stock (ACLX)
Structure Therapeutics Sponsored Ads (GPCR)
Kalvista Pharmaceuticals (KALV)
Astria Therapeutics (ATXS)
Immatics NV SHS (IMTX)
Ultragenyx Pharmaceutical (RARE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Soleno Therapeutics (SLNO)
Day One Biopharmaceuticals I (DAWN)
Savara (SVRA)
Agios Pharmaceuticals (AGIO)

View all positions for Vestal Point Capital

Top funds holding Geron Corporation

BlackRock
BlackRock
RA Capital Management
Vanguard Group
State Street Corporation
Darwin Global Management
Leucadia National Corporation
Holocene Advisors
Farallon Capital Management
Geode Capital Management
Deep Track Capital
Goldman Sachs Group
Henderson Group
Eventide Asset Management
Woodline Partners

View all funds holding Geron Corporation